Drug Side Effects
Search
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA
was reported 29 times
These drug classes are most commonly taken by patients reporting GASTROINTESTINAL NEUROENDOCRINE CARCINOMA:
#
Drug
Count
0
Corticosteroid [EPC]
5
1
Integrin Receptor Antagonist [EPC]
5
2
GLP-1 Receptor Agonist [EPC]
3
3
Proton Pump Inhibitor [EPC]
3
4
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
2
5
Janus Kinase Inhibitor [EPC]
2
6
Kinase Inhibitor [EPC]
2
7
Nonsteroidal Anti-inflammatory Drug [EPC]
2
8
Platinum-based Drug [EPC]
2
9
Topoisomerase Inhibitor [EPC]
2
10
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
11
mTOR Inhibitor Immunosuppressant [EPC]
2
12
Alkylating Drug [EPC]
1
13
Aminosalicylate [EPC]
1
14
Angiotensin Converting Enzyme Inhibitor [EPC]
1
15
Calcium Channel Blocker [EPC]
1
16
Dihydropyridine Calcium Channel Blocker [EPC]
1
17
Factor Xa Inhibitor [EPC]
1
18
Glinide [EPC]
1
19
Insulin Analog [EPC]
1
20
Interferon beta [EPC]
1
21
Leukocyte Growth Factor [EPC]
1
22
Microtubule Inhibitor [EPC]
1
23
Platelet Aggregation Inhibitor [EPC]
1
24
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
1
25
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
26
Thalidomide Analog [EPC]
1
27
Vitamin B12 [EPC]
1
28
Vitamin C [EPC]
1
29
Vitamin D [EPC]
1